• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Biogen Stock continues to CRASH!!!

He is expanding boogen's approach.

It may no longer be the who you know rather than what you know that matters.

Instead, maybe it is becoming the who, what, AND when that matters. Significantly more comprehensive.